Liontrust Investment Partners LLP Raises Holdings in Lam Research Co. (NASDAQ:LRCX)

Liontrust Investment Partners LLP grew its stake in Lam Research Co. (NASDAQ:LRCXFree Report) by 2.3% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 17,800 shares of the semiconductor company’s stock after purchasing an additional 400 shares during the quarter. Liontrust Investment Partners LLP’s holdings in Lam Research were worth $11,157,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. Bollard Group LLC boosted its position in Lam Research by 60.0% during the second quarter. Bollard Group LLC now owns 40 shares of the semiconductor company’s stock worth $26,000 after acquiring an additional 15 shares during the last quarter. BluePath Capital Management LLC acquired a new position in Lam Research in the 3rd quarter valued at about $28,000. Resurgent Financial Advisors LLC acquired a new position in Lam Research in the 2nd quarter valued at about $29,000. Steward Financial Group LLC acquired a new position in Lam Research in the 2nd quarter valued at about $32,000. Finally, OFI Invest Asset Management acquired a new position in Lam Research in the 3rd quarter valued at about $30,000. Institutional investors and hedge funds own 84.08% of the company’s stock.

Insider Buying and Selling

In related news, CAO Christina Corrreia sold 647 shares of the company’s stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $768.75, for a total transaction of $497,381.25. Following the completion of the transaction, the chief accounting officer now directly owns 5,492 shares in the company, valued at approximately $4,221,975. The sale was disclosed in a document filed with the SEC, which is available through this link. In other news, CAO Christina Corrreia sold 647 shares of the stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $768.75, for a total value of $497,381.25. Following the completion of the transaction, the chief accounting officer now owns 5,492 shares of the company’s stock, valued at $4,221,975. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Abhijit Y. Talwalkar sold 882 shares of the stock in a transaction on Tuesday, January 2nd. The stock was sold at an average price of $768.75, for a total value of $678,037.50. Following the completion of the transaction, the director now directly owns 11,604 shares of the company’s stock, valued at approximately $8,920,575. The disclosure for this sale can be found here. Insiders sold a total of 33,391 shares of company stock worth $24,130,312 in the last three months. 0.32% of the stock is owned by insiders.

Lam Research Trading Up 5.3 %

NASDAQ:LRCX traded up $45.72 on Friday, hitting $910.08. 964,777 shares of the stock were exchanged, compared to its average volume of 1,096,956. The company has a current ratio of 3.06, a quick ratio of 2.02 and a debt-to-equity ratio of 0.61. The stock has a market cap of $119.31 billion, a PE ratio of 33.42, a PEG ratio of 3.04 and a beta of 1.50. Lam Research Co. has a fifty-two week low of $467.02 and a fifty-two week high of $912.64. The stock has a fifty day moving average of $779.49 and a 200-day moving average of $700.37.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings results on Wednesday, January 24th. The semiconductor company reported $7.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.06 by $0.46. The business had revenue of $3.76 billion for the quarter, compared to analyst estimates of $3.71 billion. Lam Research had a return on equity of 44.47% and a net margin of 24.15%. The business’s revenue was down 28.8% compared to the same quarter last year. During the same period in the prior year, the company posted $10.71 EPS. As a group, equities analysts expect that Lam Research Co. will post 28.68 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 3rd. Investors of record on Wednesday, March 13th will be paid a dividend of $2.00 per share. This represents a $8.00 dividend on an annualized basis and a yield of 0.88%. Lam Research’s payout ratio is currently 30.94%.

Analyst Ratings Changes

Several brokerages recently weighed in on LRCX. Redburn Atlantic began coverage on shares of Lam Research in a research note on Wednesday, November 22nd. They set a “buy” rating and a $800.00 target price on the stock. Needham & Company LLC upped their target price on shares of Lam Research from $800.00 to $900.00 and gave the stock a “buy” rating in a research note on Thursday, January 25th. B. Riley upped their target price on shares of Lam Research from $690.00 to $700.00 and gave the stock a “neutral” rating in a research note on Thursday, October 19th. Barclays upped their target price on shares of Lam Research from $750.00 to $825.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Finally, The Goldman Sachs Group boosted their price target on shares of Lam Research from $700.00 to $912.00 and gave the stock a “buy” rating in a report on Thursday, January 25th. Nine research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Lam Research has an average rating of “Moderate Buy” and a consensus price target of $793.27.

View Our Latest Report on Lam Research

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Read More

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.